Facial aging
Conditions
Interventions
Treatment:Medium-frequency electric stimulaiton with 70% to 100% intension, 30 minutes weekly for 4 weeks
Sponsors
Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
Eligibility
Sex/Gender
All
Age
35 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Age between 35 and 70 years (inclusive), no restriction on sex; 2. Bilateral facial symmetry is generally normal; 3. Moderate to severe facial aging with FWS score >= 2; 4. No contraindications to electrical stimulation therapy; 5. Not engaged in outdoor occupations; 6. Good compliance as assessed by the investigator and able to complete follow-up visits; 7. Voluntarily participates in this study and signs the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients with a previously confirmed diagnosis of muscle or neurological disorders (e.g., facial muscle atrophy, facial paralysis, etc.); 2. Presence of metallic implants in the body (e.g., dental prostheses, cardiac pacemaker, artificial joints, etc.); 3. Pregnant or lactating women, or women planning to become pregnant within 6 months after completion of the study; 4. Skin diseases in the facial treatment area that may interfere with facial rejuvenation treatment or efficacy evaluation (e.g., eczema, allergic dermatitis, severe melasma, psoriasis, rosacea), or conditions such as obvious scarring or excessive facial hair that may significantly affect outcome assessment; 5. Participation in other clinical studies related to facial rejuvenation during the study period; 6. Patients unwilling to discontinue the use of other non-medical energy-based devices or unwilling to comply with sun protection requirements during the study period; 7. Patients who have received any facial rejuvenation treatments (e.g., medication, laser, intense pulsed light, RF, ultrasound, photodynamic therapy, etc.) within 4 weeks prior to enrollment; 8. Patients with concurrent systemic diseases, including but not limited to a history of cardiovascular disease, endocrine disorders (such as diabetes, dyslipidemia, thyroid dysfunction), hematologic diseases (such as anemia, coagulation disorders), or infectious diseases (such as herpes).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Response rate based on FWS decline index; | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient satisfaction evaluation;Frontal muscle thickness increase index;GAIS score; | — |
Countries
China
Contacts
Public ContactYao Min
Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
Outcome results
None listed